Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (CTNM)

Historical Holders from Q2 2024 to Q3 2025

Symbol
CTNM on Nasdaq
Type / Class
Equity / Class A Common Stock, $0.001 par value per share
Shares outstanding
21,500,623
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
17,478,081
Holdings value
$205,365,503
% of all portfolios
0%
Number of holders
61
Number of buys
32
Number of sells
-38
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (CTNM)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 9.9% $8,488,000 2,122,000 RA Capital Management, L.P. 18 Jul 2025
FRANKLIN RESOURCES INC 7.7% -13.3% $19,453,682 -$508,531 1,655,548 -2.5% Franklin Resources, Inc. 30 Sep 2025
SECTORAL ASSET MANAGEMENT INC 4.99% $4,297,553 950,786 Jerome G. Pfund 31 Dec 2024
PERCEPTIVE ADVISORS LLC 3.2% -53.8% $2,776,959 -$2,944,799 699,486 -51.5% Perceptive Advisors LLC 30 Jun 2025

Institutional Holders of Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (CTNM)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 17,478,081 $205,365,503 +$48,626,432 $11.75 61
2025 Q2 13,856,430 $55,287,652 -$6,405,461 $3.97 68
2025 Q1 15,121,377 $105,552,026 -$10,223,173 $6.98 62
2024 Q4 15,761,089 $230,901,673 +$20,179,605 $14.65 60
2024 Q3 13,713,806 $258,404,333 +$11,041,962 $19.14 52
2024 Q2 13,016,510 $229,220,181 +$229,145,565 $17.61 49